Literature DB >> 19463900

The role of mammalian ribonucleases (RNases) in cancer.

Wan-Cheol Kim1, Chow H Lee.   

Abstract

Ribonucleases (RNases) are a group of enzymes that cleave RNAs at phosphodiester bonds resulting in remarkably diverse biological consequences. This review focuses on mammalian RNases that are capable of, or potentially capable of, cleaving messenger RNA (mRNA) as well as other RNAs in cells and play roles in the development of human cancers. The aims of this review are to provide an overview of the roles of currently known mammalian RNases, and the evidence that associate them as regulators of tumor development. The roles of these RNases as oncoproteins and/or tumor suppressors in influencing cell growth, apoptosis, angiogenesis, and other cellular hallmarks of cancer will be presented and discussed. The RNases under discussion include RNases from the conventional mRNA decay pathways, RNases that are activated under cellular stress, RNases from the miRNA pathway, and RNases with multifunctional activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19463900     DOI: 10.1016/j.bbcan.2009.05.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Understanding the effect of magnesium ion concentration on the catalytic activity of ribonuclease H through computation: does a third metal binding site modulate endonuclease catalysis?

Authors:  Ming-Hsun Ho; Marco De Vivo; Matteo Dal Peraro; Michael L Klein
Journal:  J Am Chem Soc       Date:  2010-10-06       Impact factor: 15.419

Review 2.  RNA decay: a novel therapeutic target in bacteria.

Authors:  Tess M Eidem; Christelle M Roux; Paul M Dunman
Journal:  Wiley Interdiscip Rev RNA       Date:  2012-02-28       Impact factor: 9.957

3.  Characterization of the endoribonuclease active site of human apurinic/apyrimidinic endonuclease 1.

Authors:  Wan-Cheol Kim; Brian R Berquist; Manbir Chohan; Christopher Uy; David M Wilson; Chow H Lee
Journal:  J Mol Biol       Date:  2011-07-06       Impact factor: 5.469

4.  Expressional profiling and clinical relevance of RNase κ in prostate cancer: a novel indicator of favorable progression-free survival.

Authors:  Athina Kladi-Skandali; Konstantinos Mavridis; Andreas Scorilas; Diamantis C Sideris
Journal:  J Cancer Res Clin Oncol       Date:  2018-07-27       Impact factor: 4.553

5.  Polyadenylation ligation-mediated sequencing (PALM-Seq) characterizes cell-free coding and non-coding RNAs in human biofluids.

Authors:  Zhongzhen Liu; Taifu Wang; Xi Yang; Qing Zhou; Sujun Zhu; Juan Zeng; Haixiao Chen; Jinghua Sun; Liqiang Li; Jinjin Xu; Chunyu Geng; Xun Xu; Jian Wang; Huanming Yang; Shida Zhu; Fang Chen; Wen-Jing Wang
Journal:  Clin Transl Med       Date:  2022-07

6.  An L-RNA Aptamer that Binds and Inhibits RNase.

Authors:  Charles Olea; Joachim Weidmann; Philip E Dawson; Gerald F Joyce
Journal:  Chem Biol       Date:  2015-11-19

7.  Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.

Authors:  Feng-Qiang Yang; Jian-Hua Huang; Min Liu; Feng-Ping Yang; Wei Li; Guang-Chun Wang; Jian-Ping Che; Jun-Hua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

8.  Evaluation of Argonaute protein as a predictive marker for human clear cell renal cell carcinoma.

Authors:  Wei Li; Min Liu; Yuan Feng; Yun-Fei Xu; Jian-Ping Che; Guang-Chun Wang; Jun-Hua Zheng; Heng-Jun Gao
Journal:  Int J Clin Exp Pathol       Date:  2013-05-15

9.  Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent.

Authors:  Liron Nesiel-Nuttman; Betty Schwartz; Oded Shoseyov
Journal:  Oncotarget       Date:  2014-11-30

10.  Poly(A)-specific ribonuclease and Nocturnin in squamous cell lung cancer: prognostic value and impact on gene expression.

Authors:  Panagiotis Maragozidis; Eirini Papanastasi; Diana Scutelnic; Athina Totomi; Ioanna Kokkori; Sotirios G Zarogiannis; Theodora Kerenidi; Konstantinos I Gourgoulianis; Nikolaos A A Balatsos
Journal:  Mol Cancer       Date:  2015-11-05       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.